Policy | February 02, 2023
Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Diagnostic imaging will become an increasingly vital process in healthcare
The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
The Government of India is supporting the states in active case detection, surveillance, treatment, supply of diagnostic kits, medicines, sprays etc.
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
The Group will continue to make proactive investments of its management resources in the life science business
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
Subscribe To Our Newsletter & Stay Updated
